Back to Search Start Over

NCCN Guidelines Insights: Rectal Cancer, Version 6.2020

NCCN Guidelines Insights: Rectal Cancer, Version 6.2020

Authors :
Al B, Benson
Alan P, Venook
Mahmoud M, Al-Hawary
Mustafa A, Arain
Yi-Jen, Chen
Kristen K, Ciombor
Stacey, Cohen
Harry S, Cooper
Dustin, Deming
Ignacio, Garrido-Laguna
Jean L, Grem
Andrew, Gunn
Sarah, Hoffe
Joleen, Hubbard
Steven, Hunt
Natalie, Kirilcuk
Smitha, Krishnamurthi
Wells A, Messersmith
Jeffrey, Meyerhardt
Eric D, Miller
Mary F, Mulcahy
Steven, Nurkin
Michael J, Overman
Aparna, Parikh
Hitendra, Patel
Katrina, Pedersen
Leonard, Saltz
Charles, Schneider
David, Shibata
John M, Skibber
Constantinos T, Sofocleous
Elena M, Stoffel
Eden, Stotsky-Himelfarb
Christopher G, Willett
Alyse, Johnson-Chilla
Lisa A, Gurski
Source :
Journal of the National Comprehensive Cancer Network : JNCCN. 18(7)
Publication Year :
2020

Abstract

The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines. These updates include clarifying the definition of rectum and differentiating the rectum from the sigmoid colon; the total neoadjuvant therapy approach for localized rectal cancer; and biomarker-targeted therapy for metastatic colorectal cancer, with a focus on new treatment options for patients with BRAF V600E- or HER2 amplification-positive disease.

Details

ISSN :
15401413
Volume :
18
Issue :
7
Database :
OpenAIRE
Journal :
Journal of the National Comprehensive Cancer Network : JNCCN
Accession number :
edsair.pmid..........3f0cb5050dd6e8ce02b15b59a251f321